KRAS G12D mutation predicts lower TMB and drives immune suppression in lung adenocarcinoma
Ge Gao, Wei‐Ting Liao, Qizhi Ma, Benxia Zhang, Yue Chen, Yongsheng Wang
Topics & Concepts
KRASAdenocarcinomaCancer researchImmune systemMutantMutationImmunotherapyMedicineMutation rateImmune checkpointLung cancerCancerImmunologyBiologyOncologyGeneInternal medicineColorectal cancerGeneticsCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosisImmunotherapy and Immune Responses